Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual Meeting
PHILADELPHIA, April 08, 2024 -- Century Therapeutics , an innovative biotechnology company developing induced pluripotent stem cell -derived cell therapies in immuno-oncology and autoimmune and...
United States Julie Seidel Noor Exchange Commission Derived Cell Board Number Adoptive Cell Therapies
Source: marketscreener.com